Clinical features of drug-induced Parkinsonism

被引:5
|
作者
Shiraiwa, Nobuko [1 ]
Tamaoka, Akira [2 ]
Ohkoshi, Norio [1 ]
机构
[1] Tsukuba Univ Technol, Dept Hlth Sci, Course Neurol, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki, Japan
关键词
Drug-induced Parkinsonism; sulpiride; Parkinson's disease; malignant syndrome; oromandibular dyskinesia;
D O I
10.4081/ni.2018.7877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson's disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 50 条
  • [1] Drug-induced parkinsonism
    Mena, Maria A.
    de Yebenest, Justo G.
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (06) : 759 - 771
  • [2] Drug-Induced Parkinsonism
    Shin, Hae-Won
    Chung, Sun Ju
    JOURNAL OF CLINICAL NEUROLOGY, 2012, 8 (01): : 15 - 21
  • [3] DRUG-INDUCED PARKINSONISM
    WILSON, JA
    PRIMROSE, WR
    BRITISH MEDICAL JOURNAL, 1986, 293 (6552): : 957 - 957
  • [4] Drug-induced parkinsonism
    Factor, SA
    MOVEMENT DISORDERS, 2006, 21 : S31 - S31
  • [5] Drug-induced parkinsonism
    Van Gerpen, JA
    NEUROLOGIST, 2002, 8 (06) : 363 - 370
  • [6] Drug-induced parkinsonism
    Nguyen, N
    Pradel, V
    Micallef, J
    Montastruc, JL
    Blin, O
    THERAPIE, 2004, 59 (01): : 105 - 112
  • [7] Drug-Induced Parkinsonism
    Garg, Kanwaljeet
    Rajan, Roopa
    Singh, Manmohan
    NEUROLOGY INDIA, 2021, 69 (02) : 437 - 438
  • [8] DRUG-INDUCED PARKINSONISM
    ROZZINI, R
    MISSALE, C
    GADOLA, M
    LANCET, 1985, 1 (8420): : 113 - 113
  • [9] Drug-Induced Parkinsonism
    Friedman, Joseph H.
    MOVEMENT DISORDERS, 2017, 32 (07) : 1111 - 1111
  • [10] Drug-induced parkinsonism
    Levin, O. S.
    Shindryaeva, N. N.
    Anikina, M. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (08) : 76 - 81